• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    LSNE Acquires PSC Biotech’s Parenteral Mfg. Facility

    Financial Report: AbbVie

    Financial Report: West

    PAREXEL Appoints Chief Commercial Officer

    Interphex 2018: Video Highlights
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    LSNE Acquires PSC Biotech’s Parenteral Mfg. Facility

    Bristol-Myers Squibb Launches New Discovery Facility

    INTERPHEX: Antares Vision Explains LYO-CHECK Machine

    PCI Launches High Containment Packaging at Ireland Site

    ADC Bio Plans U.S. Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Bristol-Myers Squibb Launches New Discovery Facility

    ADC Bio Plans U.S. Expansion

    Cambrex Continues Expansion Plans with New Lab

    Catalent Bolsters Drug Development Capabilities

    Q Therapeutics, REPROCELL Form MAGiQ Therapeutics
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Avista Pharma Solutions

    Almac Group

    Alcami

    Pfizer CentreOne Contract Manufacturing

    IQVIA
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Cambridge Major Appoints SciTech VP

    Raje to provide strategic leadership for API organization

    Related CONTENT
    • Cambridge Major Laboratories
    • Cambridge Major Sites Inspected, Launches API
    • Smithers Pharma Names President
    • Cambridge Major Expands API Facility
    • Cambridge Major Appoints Sawicki
    11.27.12
    Dr. Prasad Raje has been appointed vice president of science and technology at Cambridge Major Laboratories. Dr. Raje will provide technical and strategic leadership and will have overall responsibility for the company’s API development organization. He will also play a key role in implementing new technologies and services.
     
    Dr. Raje has more than 15 years of pharmaceutical industry experience and a track record of providing substantial organizational growth. He previously served as president of Smithers Pharma Services, a CRO with expertise in analytical services, pharmaceutical R&D, and agrochemicals. Dr. Raje also held positions with AMRI, initially as section head, chemical development, and later as president and managing director of AMRI India.  
     
    “Dr. Raje brings a proven track record of solving the most complex chemistry challenges relating to the development of APIs, solid state chemistry, formulation development, and analytical chemistry,” said Brian Scanlan, president and chief executive officer of CML. “His in-depth knowledge across the entire drug development process will help guide our clients’ development programs from early pre-clinical through to commercialization, said Scanlan. His passion for chemistry will expand our culture of innovation and technical excellence, cementing our leading position in the industry.”
    Related Searches
    • formulation
    • CRO
    • Formulation Development
    • Development
    Suggested For You
    Valeant Appoints Chief Quality Officer Valeant Appoints Chief Quality Officer
    AMRI Adds Quality and Compliance Role AMRI Adds Quality and Compliance Role
    AAI/CML Becomes Alcami  AAI/CML Becomes Alcami
    AAI/CML Becomes Alcami AAI/CML Becomes Alcami
    AAI/CML Expands E-WorkBook Platform AAI/CML Expands E-WorkBook Platform
    AAI/CML Launches ProForm Select AAI/CML Launches ProForm Select
    AAI/CML Expands Mfg. Capabilities in The Netherlands AAI/CML Expands Mfg. Capabilities in The Netherlands
    EMD Serono Names U.S. CMO EMD Serono Names U.S. CMO
    Water Street Completes Sale of AAIPharma to CML Water Street Completes Sale of AAIPharma to CML
    AAIPharma, Cambridge Major Labs To Merge AAIPharma, Cambridge Major Labs To Merge
    Cambridge Major Appoints Sawicki Cambridge Major Appoints Sawicki
    Cambridge Major Expands API Facility
 Cambridge Major Expands API Facility
    Smithers Pharma Names President Smithers Pharma Names President
    Cambridge Major Sites Inspected, Launches API Cambridge Major Sites Inspected, Launches API
    Cambridge Major Laboratories Cambridge Major Laboratories

    Related Breaking News

    • Analytical Services | Breaking News | Facilities | Industry News | R&D
      Cambrex Continues Expansion Plans with New Lab

      Cambrex Continues Expansion Plans with New Lab

      Completes $3.2M analytical research and development laboratory at its High Point, NC facility
      04.24.18

    • Breaking News | Drug Development | Industry News
      Catalent Bolsters Drug Development Capabilities

      Catalent Bolsters Drug Development Capabilities

      Invests $5M at Somerset site to create new drug development and modified release center of excellence
      04.24.18

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

      Q Therapeutics, REPROCELL Form MAGiQ Therapeutics

      To treat demyelinating and degenerative diseases of the CNS
      04.23.18


    • Bio News | Collaborations & Alliances | Drug Development | Formulation Development | Industry News | R&D
      Noramco, SPI Pharma Sign Agreement

      Noramco, SPI Pharma Sign Agreement

      To develop a set of “value-added” formulation packages for global pharma manufacturers of finished dosage forms
      04.23.18

    • Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
      Codexis, Porton Enter Collaboration

      Codexis, Porton Enter Collaboration

      To accelerate the creation and commercialization of new, low-cost, sustainable manufacturing processes
      04.23.18

    • Analytical Services | Industry News
      AMRI Expands NMR Spec Capabilities in Europe

      AMRI Expands NMR Spec Capabilities in Europe

      Adds Bruker AVANCE NEO 600 MHz NMR Spectrometer
      04.23.18


    • Breaking News | Drug Development | Facilities | Industry News | Laboratory Testing
      WuXi AppTec Opens Laboratory Testing Facility in NJ

      WuXi AppTec Opens Laboratory Testing Facility in NJ

      Expands site in the U.S. for drug development testing services
      04.20.18

    • Bio News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Drug Development | Industry News
      STA, PhoenixMD Enter Manufacturing Agreement

      STA, PhoenixMD Enter Manufacturing Agreement

      To manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women
      04.18.18

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      ProBioGen, Tizona Therapeutics Enter Collaboration

      ProBioGen, Tizona Therapeutics Enter Collaboration

      To develop immune system centered treatments for cancer
      04.18.18


    • Analytical Services | Breaking News | Industry News | Parenterals
      AMRI Highlights Suite of Contract Services

      AMRI Highlights Suite of Contract Services

      Visit Booth 1129 at Interphex 2018 to learn more about the complete suite of drug development and manufacturing solutions
      04.17.18

    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Telix, INSERM, and ARRONAX Enter Agreement

      Telix, INSERM, and ARRONAX Enter Agreement

      To explore the feasibility of using several of Telix's clinical targeting agents with astatine
      04.16.18

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Servier Acquires Shire Oncology Business for $2.4B

      Servier Acquires Shire Oncology Business for $2.4B

      The gross assets that are the subject of the transaction are approximately $1.6 billion
      04.16.18

    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Idera, Pillar Partners Enter Agreement

      Idera, Pillar Partners Enter Agreement

      Pillar Partners will provide funding to support three clinical trials to expand the clinical research of Idera's IMO-2125
      04.16.18

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Kineta, Genentech Enter Collaboration

      Kineta, Genentech Enter Collaboration

      To develop Kineta's α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain
      04.16.18

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Facilities | Industry News
      Sartorius Stedim Biotech, Penn State Enter Partnership

      Sartorius Stedim Biotech, Penn State Enter Partnership

      To support the education and preparation of the next generation of biotechnology leaders
      04.16.18

    Breaking News
    • LSNE Acquires PSC Biotech’s Parenteral Mfg. Facility
    • Financial Report: AbbVie
    • Financial Report: West
    • PAREXEL Appoints Chief Commercial Officer
    • Interphex 2018: Video Highlights
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.